Hikma To Divest Phenytoin, Promethazine Injectables To Acquire Baxter Business
This article was originally published in The Pink Sheet Daily
Executive Summary
X-Gen Pharmaceuticals will purchase the products as part of the FTC-mandated divesture. Without the transaction, Hospira would have been the only other company that sold the two drugs once Hikma acquired Baxter's entire generic injectable business.